Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01725399 · ClinicalTrials.gov registry record · NA
Does First Oral Intake After Emergence Predict the Incidence of Post-operative Vomiting in Children?
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 183
- Enrollment target
NCT01725399 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 183 participants.
The verdict
NCT01725399, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 183 participants
- Enrollment target
Study Summary
Second only to pain, nausea and vomiting are the most uncomfortable complications of surgery and anesthesia. Unfortunately, our best defense against post-operative nausea and vomiting, a medicine called ondansetron (Zofran), is in dire national shortage. Consequently, non-pharmacological methods of prevention and treatment for post-operative nausea and vomiting have increased import. Following emergence from general anesthesia, children often request food and drink. There have been no studies to date that definitively determine the optimal first food or drink choice for these children. This study proposes to randomize children to either water or juice first intake following surgery. The investigators expect to find that children who consume glucose are less likely to vomit than those who first receive water.
Interventions
- OTHER Water
- OTHER Apple Juice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2012-10 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01725399
The ClinicalTrials.gov registry entry for NCT01725399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Water is the first listed.
NCT01725399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01725399 about?
NCT01725399 is a clinical study titled "Does First Oral Intake After Emergence Predict the Incidence of Post-operative Vomiting in Children?". Second only to pain, nausea and vomiting are the most uncomfortable complications of surgery and anesthesia. Unfortunately, our best defense against post-operative nausea and vomiting, a medicine called ondansetron (Zofran), is in dire national shortage. Consequently, non-pharmacological methods of ...
What is the current status of trial NCT01725399?
This trial is currently completed. It is a NA study. The enrollment target is 183 participants. The study started on 2012-10. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01725399?
The interventions under investigation include: Water (OTHER), Apple Juice (OTHER).
Who is sponsoring clinical trial NCT01725399?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.